Back to Eosinophilic Granulomatosis with Polyangiitis

Research record changes

The latest 100 trial status and retraction changes detected since change tracking began. Dates show when RareWays recorded the change, which may be later than the source update. Earlier history is unavailable.

  1. Study of Mepolizumab-based Regimen Compared to Conventional Therapeutic Strategy in Patients With Eosinophilic Granulomatosis With Polyangiitis (E-merge)

    ACTIVE NOT RECRUITING → COMPLETED

    Recorded 2026-10-01

    View record